4//SEC Filing
Burgess Michael F. 4
Accession 0001209191-23-052997
CIK 0001764974other
Filed
Oct 16, 8:00 PM ET
Accepted
Oct 17, 6:37 PM ET
Size
5.6 KB
Accession
0001209191-23-052997
Insider Transaction Report
Form 4
Burgess Michael F.
DirectorInterim Chief Medical Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2023-10-16+11,464→ 11,464 totalExercise: $2.61Exp: 2033-10-15→ Common Stock (11,464 underlying)
Footnotes (1)
- [F1]One fourth (1/4th) of the shares subject to the option award shall vest on October 12, 2024, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.
Documents
Issuer
Turnstone Biologics Corp.
CIK 0001764974
Entity typeother
Related Parties
1- filerCIK 0001801745
Filing Metadata
- Form type
- 4
- Filed
- Oct 16, 8:00 PM ET
- Accepted
- Oct 17, 6:37 PM ET
- Size
- 5.6 KB